Simon Moore discusses non-clinical development channels: technical strategies, formulations and devices.
Stay of execution for ageing blockbuster
Breathing space for GSK as Mylan’s Advair copy rejected
$21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.
Propeller Health set for expansion with latest funding round